查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1684379

哺乳動物細胞發酵技術市場，按類型、按應用、按最終用途、按國家和地區 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率和預測

Mammalian Cell Fermentation Technology Market, By Type, By Application, By End-use, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 311 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年哺乳動物細胞發酵技術市場規模價值為 507.8943 億美元，2025 年至 2032 年的複合年成長率為 8.99%。

哺乳動物細胞發酵技術市場-市場動態

生物製劑和生物相似藥需求不斷成長，推動市場成長

由於對生物相似藥和生物製劑的需求不斷增加，哺乳動物細胞發酵技術產業正在經歷顯著的成長。這些治療對於控制各種疾病（包括傳染病、癌症和自體免疫疾病）非常重要。此外，隨著製藥公司對新型生物製劑的研發投入加大，哺乳動物細胞發酵技術也不斷擴展。然而，限制該技術廣泛應用的一個重要因素是其製造流程的高成本。此外，癌症、糖尿病和心臟病等慢性病的增加導致哺乳動物細胞發酵技術市場的成長。由於許多疾病需要長期治療（通常採用生物製劑），因此對哺乳動物細胞發酵技術的需求持續存在。因此，由於對生物相似藥和生物製劑的需求不斷成長以及慢性病的增加，哺乳動物細胞發酵技術市場預計未來幾年將會成長。

哺乳動物細胞發酵技術市場-關鍵見解

根據我們的研究分析師的分析，預測期內（2025-2032 年），全球市場預計年複合成長率約為 8.99%

根據類型細分，預計中國倉鼠卵巢 (CHO) 細胞發酵將在 2024 年佔據最大市場佔有率

根據應用細分，單株抗體是 2024 年的主要應用

根據最終用途細分，CMO 和 CDMO 是 2024 年的主要最終用途

從地區來看，北美是 2024 年最大的收入來源

哺乳動物細胞發酵技術市場-細分分析：

全球哺乳動物細胞發酵技術市場根據類型、應用、最終用途和地區進行細分。

市場依類型分為五類：小倉鼠腎（BHK）細胞發酵、中國倉鼠卵巢（CHO）細胞發酵、人類胚胎腎（HEK）細胞發酵、鼠骨髓瘤細胞發酵等。中國倉鼠卵巢（CHO）細胞發酵領域預計將佔據市場主導地位。 CHO 細胞因其能夠有效製造複雜的治療性蛋白質而引起了廣泛關注。此外，需求的成長可歸因於多種因素，例如培養基和條件的最佳化、增強細胞株發育的基因工程技術的進步以及強大的監管環境。

根據應用，市場分為六類：酵素、荷爾蒙、單株抗體、重組蛋白、疫苗、其他。單株抗體領域可能佔據最高的市場佔有率，因為高採用率可以歸因於抗體在診斷和治療應用中發揮的關鍵作用，從而導致對穩健生產方法的需求不斷成長。此外，細胞株開發、生物反應器技術和生物加工技術的進步，帶來了更好的產品品質、更高的產量和更高效的生產過程，推動了該領域的爆炸式擴張。同樣，對精準標靶治療的需求和慢性病的日益普及也刺激了對哺乳動物抗體的需求。

根據最終用途，市場分為三類：學術和研究機構、生物製藥公司以及 CMO 和 CDMO。由於 CDMO 和 CMO 擅長的複雜製造技術，CMO 和 CDMO 行業很可能在預測期內保持主導地位。此外，品質標準和監管要求更加嚴格，因此製藥企業需要與信譽良好的 CMO 和 CDMO 合作，以保持滿足這些要求的能力。

哺乳動物細胞發酵技術市場-地理洞察

北美佔據哺乳動物細胞發酵技術市場的最大佔有率。市場的成長歸功於該地區高度發展的醫療保健產業、有利的政府法規以及重要生物製藥公司的強大影響力。此外，對生物製劑和生物相似藥的需求不斷成長以及慢性病發病率的上升是推動該地區市場成長的因素。

由於能夠以較低成本獲得訓練有素的員工、有利的監管環境以及跨國公司的投資不斷增加，亞太地區可能會快速成長。

哺乳動物細胞發酵技術市場-競爭格局：

哺乳動物細胞發酵市場受到細胞培養技術進步的推動。哺乳動物細胞發酵技術在眾多應用領域的需求不斷成長，為主要參與者創造了各種市場機會。這些行業參與者主要採用涉及收購、合作、夥伴關係和合併等多種策略來建立全球影響力並保持市場競爭。此外，持續進行的生物加工方法研發工作以及生物製造基礎設施支出的增加也促進了市場的進步。例如，2023年1月，復星醫藥與上海復宏漢霖生物科技股份有限公司在美國簽署獨家授權協議，將復宏漢霖自主開發的抗PD-1單株抗體serplulimab商業化。這標誌著復星醫藥在美國發展的重要轉捩點。

最新動態：

2023 年 7 月，Lonza 推出了 TheraPRO(R) CHO 培養基系統，這是一個創新的細胞培養平台，與 GS-CHO 細胞系一起使用時可簡化程序並最佳化生產力和蛋白質品質。該技術的推出支持生產治療性蛋白質的生物技術和製藥公司提高產品質量，同時縮短產品上市時間。

目錄

第 1 章：哺乳動物細胞發酵技術市場概述

  • 研究範圍
  • 市場估計年限

第 2 章：執行摘要

  • 市場片段
    • 哺乳動物細胞發酵技術市場片段（按類型）
    • 哺乳動物細胞發酵技術市場片段（依應用）
    • 哺乳動物細胞發酵技術市場片段（依最終用途）
    • 哺乳動物細胞發酵技術市場（按國家/地區）
    • 哺乳動物細胞發酵技術市場片段（按地區）
  • 競爭洞察

第 3 章：哺乳動物細胞發酵技術關鍵市場趨勢

  • 哺乳動物細胞發酵技術市場促進因素
    • 市場促進因素的影響分析
  • 哺乳動物細胞發酵技術市場限制
    • 市場限制的影響分析
  • 哺乳動物細胞發酵技術的市場機會
  • 哺乳動物細胞發酵技術市場未來趨勢

第 4 章：哺乳動物細胞發酵技術產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景規劃
  • 規範架構分析

第5章：哺乳動物細胞發酵技術市場：地緣政治緊張局勢升級的影響

  • 新冠肺炎疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第 6 章：哺乳動物細胞發酵技術市場格局

  • 哺乳動物細胞發酵技術市佔分析，2024 年
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第 7 章：哺乳動物細胞發酵技術市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 幼倉鼠腎（BHK）細胞發酵
    • 中國倉鼠卵巢（CHO）細胞發酵
    • 人類胚胎腎 (HEK) 細胞發酵
    • 鼠骨髓瘤細胞發酵
    • 其他

第 8 章：哺乳動物細胞發酵技術市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 酵素
    • 荷爾蒙
    • 單株抗體
    • 重組蛋白
    • 疫苗
    • 其他

第 9 章：哺乳動物細胞發酵技術市場 - 依最終用途

  • 概述
    • 按最終用途分類的細分市場佔有率分析
    • 學術及研究機構
    • 生物製藥公司
    • CMO 和 CDMO

第 10 章：哺乳動物細胞發酵技術市場-按地區

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美哺乳動物細胞發酵技術主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模和預測（按類型）
    • 北美市場規模與預測，按應用分類
    • 北美市場規模及預測（依最終用途）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲哺乳動物細胞發酵技術主要製造商
    • 歐洲市場規模及預測（按國家）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模和預測，按應用
    • 歐洲市場規模及預測（依最終用途）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區哺乳動物細胞發酵技術主要製造商
    • 亞太地區市場規模及預測（依國家/地區分類）
    • 亞太地區市場規模及預測（按類型）
    • 亞太地區市場規模及預測（按應用分類）
    • 亞太地區市場規模及預測（依最終用途分類）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲 (LATAM)
    • 概述
    • 拉丁美洲哺乳動物細胞發酵技術主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（按類型）
    • 拉丁美洲市場規模及預測（按應用分類）
    • 拉丁美洲市場規模及預測（依最終用途分類）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲 (MEA)
    • 概述
    • 中東和非洲哺乳動物細胞發酵技術主要製造商
    • MEA 市場規模及預測（依國家/地區分類）
    • MEA 市場規模和預測（按類型）
    • MEA 市場規模及預測（按應用）
    • MEA 市場規模及預測（依最終用途）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其他地區

第 11 章：主要供應商分析-哺乳動物細胞發酵技術產業

  • 競爭性基準化分析
    • Competitive Dashboard
    • Competitive Positioning
  • 公司簡介
    • AstraZeneca
    • Danaher
    • Thermo Fisher Scientific, Inc.
    • Regeneron Pharmaceuticals
    • Merck KGaA
    • Lonza
    • Gilead Sciences
    • F. Hoffmann-La Roche Ltd
    • Moderna, Inc
    • Bristol-Myers Squibb
    • Amgen
    • Sartorius AG
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4754

REPORT HIGHLIGHT

Mammalian cell fermentation technology Market size was valued at US$ 50,789.43 Million in 2024, expanding at a CAGR of 8.99% from 2025 to 2032.

Mammalian cells are widely used for producing therapeutic proteins like vaccines, monoclonal antibodies, and other biologics, along with various source materials like Human Embryonic Kidney (HEK) cells, Chinese Hamster Ovary (CHO) cells, and others. The mammalian cell fermentation technology industry will likely see significant growth in the forecasted years due to several factors, such as the rising demand for biosimilars and biologics, the increasing prevalence of chronic diseases, and advancements in mammalian cell culture techniques.

Mammalian Cell Fermentation Technology Market- Market Dynamics

Increasing demand for biologics and biosimilars to propel market growth

The mammalian cell fermentation technology industry is witnessing a significant rise due to the rising demand for biosimilars and biologics. These treatments are important in managing various conditions, including infectious diseases, cancer, and autoimmune conditions. Additionally, mammalian cell fermentation technology keeps expanding as pharmaceutical firms invest more in the creation of novel biologics. However, a vital factor restraining the widespread use of this technology is the high expenses associated with its manufacturing process. Furthermore, the rise in chronic diseases like cancer, diabetes, and heart disease resulted in a growth in the mammalian cell fermentation technology market. There is an ongoing demand for mammalian cell fermentation technologies as many diseases need long-term treatment, often with biologics. As a result, the market for mammalian cell fermentation technology is projected to grow over the coming years owing to the constant demand for biosimilars and biologics along with the rise in chronic illnesses.

Mammalian Cell Fermentation Technology Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.99% over the forecast period (2025-2032)

Based on type segmentation, Chinese hamster ovary (CHO) cell fermentation was predicted to show maximum market share in the year 2024

Based on application segmentation, monoclonal antibodies was the leading application in 2024

Based on end-use segmentation, CMOs & CDMOs was the leading end-use in 2024

On the basis of region, North America was the leading revenue generator in 2024

Mammalian Cell Fermentation Technology Market- Segmentation Analysis:

The global mammalian cell fermentation technology market is segmented on the basis of type, application, end-use, and region.

The market is divided into five categories based on type: baby hamster kidney (BHK) cell fermentation, chinese hamster ovary (CHO) cell fermentation, human embryonic kidney (HEK) Cell fermentation, murine myeloma cell fermentation, and others. The Chinese hamster ovary (CHO) cell fermentation sector is expected to dominate the market. CHO cells have prompted immense attention because of their ability to efficiently manufacture complex therapeutic proteins. Additionally, the rise in demand can be attributed to various factors such as the optimization of culture media and conditions, advancements in genetic engineering techniques for enhancing cell line development, and a robust regulatory environment.

The market is divided into six categories based on application: enzymes, hormones, monoclonal antibodies, recombinant proteins, vaccines, others. The monoclonal antibodies segment is likely to hold the highest market share as high adoption can be attributed to the crucial role that antibodies play in diagnostic and therapeutic applications, leading to growing demand for robust production methods. In addition, advancements in cell line development, bioreactor technologies, and bioprocessing techniques, leading to better product quality, higher yields, and efficient production processes, have fueled the segment's explosive expansion. Likewise, the need for precisely targeted therapies and the increasing prevalence of chronic diseases have also fueled the demand for mammalian antibodies.

The market is divided into three categories based on end-use: academic & research institutes, biopharmaceutical companies, and CMOs & CDMOs. The CMOs & CDMOs sector is likely to maintain its dominance during the forecast period due to the complex manufacturing techniques that CDMOs and CMOs specialize in. These organizations provide a simplified and affordable solution for businesses aiming to outsource their manufacturing processes, allowing them to concentrate on development and research. Moreover, quality standards and regulatory requirements are more stringent, thereby pharmaceutical businesses to collaborate with reputable CMOs and CDMOs that maintain the proficiency to comply with these demands.

Mammalian Cell Fermentation Technology Market- Geographical Insights

North America accounts for the largest share of the mammalian cell fermentation technology market. The market growth is attributed to the region's highly developed healthcare sector, favorable government regulations, and a strong presence of significant biopharmaceutical companies. Moreover, the rising demand for biologics and biosimilars and the rising incidence of chronic illnesses are attributed to driving the region's market growth.

The Asia Pacific region is likely to increase at a swift rate owing to the accessibility of trained staff at a reduced cost, the favorable regulatory environment, and rising investments by multinational corporations.

Mammalian Cell Fermentation Technology Market- Competitive Landscape:

The market for fermenting mammalian cells is being driven by technological advancements in cell culture. The rising demand for mammalian cell fermentation technology for numerous applications has created various market possibilities for major players to capitalize on. These industry players primarily adopt several strategies that involve acquisitions, collaborations, partnerships, and mergers to establish a global footprint and maintain market competition. Moreover, the market's progress is fostered by the ongoing research and development efforts to enhance bioprocessing methods, along with the rising spending on biomanufacturing infrastructure. For instance, in January 2023, Fosun Pharmahas signed an exclusive license agreement with Shanghai Henlius Biotech, Inc. in the United States (US) for the commercialization of Henlius independently developed anti-PD-1 monoclonal antibody (mAb) serplulimab. This marks a significant turning point for Fosun Pharma's development in the US.

Recent Developments:

In July 2023, Lonza launched the TheraPRO(R) CHO Media System, an innovative cell culture platform that streamlines procedures and optimizes productivity and protein quality when utilized with GS-CHO cell lines. The launch of this technology supports biotechnology and pharmaceutical companies that manufacture therapeutic proteins to enhance product quality while streamlining time-to-market.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • AstraZeneca
  • Danaher
  • Thermo Fisher Scientific, Inc.
  • Regeneron Pharmaceuticals
  • Merck KGaA
  • Lonza
  • Gilead Sciences
  • F. Hoffmann-La Roche Ltd
  • Moderna, Inc
  • Bristol-Myers Squibb
  • Amgen
  • Sartorius AG
  • Others

GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Baby Hamster Kidney (BHK) Cell Fermentation
  • Chinese Hamster Ovary (CHO) Cell Fermentation
  • Human Embryonic Kidney (HEK) Cell Fermentation
  • Murine Myeloma Cell Fermentation
  • Others

GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Enzymes
  • Hormones
  • Monoclonal Antibodies
  • Recombinant Proteins
  • Vaccines
  • Others

GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Academic & Research Institutes
  • Biopharmaceutical Companies
  • CMOs & CDMOs

GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Mammalian Cell Fermentation Technology Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Mammalian Cell Fermentation Technology Market Snippet by Type
    • 2.1.2. Mammalian Cell Fermentation Technology Market Snippet by Application
    • 2.1.3. Mammalian Cell Fermentation Technology Market Snippet by End-use
    • 2.1.4. Mammalian Cell Fermentation Technology Market Snippet by Country
    • 2.1.5. Mammalian Cell Fermentation Technology Market Snippet by Region
  • 2.2. Competitive Insights

3. Mammalian Cell Fermentation Technology Key Market Trends

  • 3.1. Mammalian Cell Fermentation Technology Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Mammalian Cell Fermentation Technology Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Mammalian Cell Fermentation Technology Market Opportunities
  • 3.4. Mammalian Cell Fermentation Technology Market Future Trends

4. Mammalian Cell Fermentation Technology Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Mammalian Cell Fermentation Technology Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Mammalian Cell Fermentation Technology Market Landscape

  • 6.1. Mammalian Cell Fermentation Technology Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Mammalian Cell Fermentation Technology Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024&2032 (%)
    • 7.1.2. Baby Hamster Kidney (BHK) Cell Fermentation
    • 7.1.3. Chinese Hamster Ovary (CHO) Cell Fermentation
    • 7.1.4. Human Embryonic Kidney (HEK) Cell Fermentation
    • 7.1.5. Murine Myeloma Cell Fermentation
    • 7.1.6. Others

8. Mammalian Cell Fermentation Technology Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024&2032 (%)
    • 8.1.2. Enzymes
    • 8.1.3. Hormones
    • 8.1.4. Monoclonal Antibodies
    • 8.1.5. Recombinant Proteins
    • 8.1.6. Vaccines
    • 8.1.7. Others

9. Mammalian Cell Fermentation Technology Market - By End-use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-use, 2024&2032 (%)
    • 9.1.2. Academic & Research Institutes
    • 9.1.3. Biopharmaceutical Companies
    • 9.1.4. CMOs & CDMOs

10. Mammalian Cell Fermentation Technology Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Mammalian Cell Fermentation Technology Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Mammalian Cell Fermentation Technology Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Mammalian Cell Fermentation Technology Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Mammalian Cell Fermentation Technology Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Mammalian Cell Fermentation Technology Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Mammalian Cell Fermentation Technology Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. AstraZeneca
    • 11.2.2. Danaher
    • 11.2.3. Thermo Fisher Scientific, Inc.
    • 11.2.4. Regeneron Pharmaceuticals
    • 11.2.5. Merck KGaA
    • 11.2.6. Lonza
    • 11.2.7. Gilead Sciences
    • 11.2.8. F. Hoffmann-La Roche Ltd
    • 11.2.9. Moderna, Inc
    • 11.2.10. Bristol-Myers Squibb
    • 11.2.11. Amgen
    • 11.2.12. Sartorius AG
    • 11.2.13. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us